Viral Infections of Humans: Epidemiology and Control

Dear Colleagues,

Viral infections pose a threat to human health and outbreaks such as the COVID-19 pandemic have been devastating. Pathogens such as the influenza virus or respiratory syncytial virus substantially contribute to respiratory disease burden. Acute viral gastroenteritis and hepatitis are prime causes of changes in disability-adjusted life years in developing countries. Elimination of viral hepatitis is delayed by an insufficient roll-out of HBV vaccines and access to HCV treatments. Eradication of vaccine-type human papillomavirus is expected to be cost-effective in eliminating cervical cancer. Screening programs need to be scaled up to prevent human T-lymphotropic virus type 1 infections and associated diseases. Novel therapeutic and preventive strategies are required to achieve the cure and elimination of HIV. Viral haemorrhagic fever outbreaks require the rapid deployment of countermeasures. An increasing number of countries are implementing integrated control strategies of arboviral diseases and vectors in the context of climate change. There is a need to promote one-health approaches, strengthen public health programs, implement laboratory networks and point-of-care testing, evaluate population-level immunity and susceptibility to pathogens, and develop new vaccines and therapeutics.

This Special Issue welcomes contributions (original research articles, reviews, short communications) on human viral infection epidemiology and control. We anticipate sharing innovations in the prevention, diagnostics and treatment, and spotlight practical experiences of local, regional or international interventions struggling with viral diseases.

Prof. Dr. Raymond Césaire
Prof. Dr. Carlos Brites
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.